Safety and Pharmacokinetics of Intravenous Zanamivir Treatment in Hospitalized Adults With Influenza: An Open-label, Multicenter, Single-Arm, Phase II Study
- 27 August 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 209 (4), 542-550
- https://doi.org/10.1093/infdis/jit467
Abstract
Background. Intravenous zanamivir is a neuraminidase inhibitor suitable for treatment of hospitalized patients with severe influenza.Keywords
This publication has 28 references indexed in Scilit:
- Characteristics of a Widespread Community Cluster of H275Y Oseltamivir-Resistant A(H1N1)pdm09 Influenza in AustraliaThe Journal of Infectious Diseases, 2012
- Zanamivir Pharmacokinetics and Pulmonary Penetration into Epithelial Lining Fluid following Intravenous or Oral Inhaled Administration to Healthy Adult SubjectsAntimicrobial Agents and Chemotherapy, 2011
- Duration of viral shedding in hospitalized patients infected with pandemic H1N1BMC Infectious Diseases, 2011
- Statistical estimates of absenteeism attributable to seasonal and pandemic influenza from the Canadian Labour Force SurveyBMC Infectious Diseases, 2011
- Clinical Experience in Adults and Children Treated with Intravenous Peramivir for 2009 Influenza A (H1N1) Under an Emergency IND Program in the United StatesClinical Infectious Diseases, 2011
- Assessment of Pandemic and Seasonal Influenza A (H1N1) Virus Susceptibility to Neuraminidase Inhibitors in Three Enzyme Activity Inhibition AssaysAntimicrobial Agents and Chemotherapy, 2010
- Critically Ill Patients With 2009 Influenza A(H1N1) Infection in CanadaPublished by American Medical Association (AMA) ,2009
- Pneumonia and Respiratory Failure from Swine-Origin Influenza A (H1N1) in MexicoThe New England Journal of Medicine, 2009
- Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in HumansThe New England Journal of Medicine, 2009
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976